Explore

Mother Uninformed of Baby's Fatal Birth Trauma Sparks Maternity Care Review

Mother Uninformed of Baby's Fatal Birth Trauma Sparks Maternity Care Review

Kayla Palmer, a mother from West Bromwich, was not informed of the critical condition of her newborn son, Hendrix, who suffered a fatal brain injury due to lack of oxygen at birth. The incident occurred at Midland Metropolitan University Hospital, leading to a national review of maternity care. Palmer only discovered her son's condition when she saw him in neonatal care, covered in wires and tubes. The hospital trust has acknowledged delays in care and communication failures. This case is part of a broader investigation into maternity services led by Baroness Amos, highlighting systemic issues such as equipment shortages and delayed medical responses.

Health Experts Warn of Decline in Infant Vitamin K Shots, Raising Health Concerns

Health Experts Warn of Decline in Infant Vitamin K Shots, Raising Health Concerns

A recent study by the American Medical Association has highlighted a significant decline in the number of infants receiving vitamin K shots since 2017. The study reports a 77% increase in the number of infants not receiving this essential shot, which is crucial for preventing vitamin K deficiency bleeding, a potentially life-threatening condition. The vitamin K shot is typically administered to newborns to aid in blood clotting and prevent serious bleeding issues. Health experts are concerned about this trend, as the lack of vitamin K can lead to severe health complications in infants.

Study Reveals Evening Antihypertensive Therapy Reduces Heart Failure Risk

Study Reveals Evening Antihypertensive Therapy Reduces Heart Failure Risk

A recent study published in Nature examines the impact of timing on antihypertensive therapy and its effects on heart failure, myocardial infarction, stroke, and all-cause death. The study, which analyzed data from the TIME and BedMed trials involving 24,461 patients, found that evening antihypertensive therapy is associated with a 23% lower risk of heart failure compared to morning therapy. The trials recorded 248 heart failures, 371 myocardial infarctions, 331 strokes, and 1,044 all-cause deaths. The hazard ratios for evening versus morning therapy were calculated, showing significant benefits for heart failure but not for other outcomes.

Texas A Scientists Develop Technique to Slow Aging by Boosting Cellular Energy

Texas A Scientists Develop Technique to Slow Aging by Boosting Cellular Energy

Researchers at Texas A&M have developed a new technique aimed at slowing the aging process by enhancing the energy production of aging and damaged cells. This method involves recharging cells by replacing their mitochondria, the cell's powerhouses, with new ones. The study, published in the Proceedings of the National Academy of Sciences, suggests potential applications for treating conditions like Alzheimer's and diabetes. Although the technique is still in its early stages and has only been tested in laboratory settings, animal trials are anticipated. The process involves converting a patient's cells into stem cells, treating them with 'nanoflowers,' and reintroducing them into the patient. However, the long-term safety of these nanoflowers and their key component, molybdenum disulfide, remains unproven.

VIDEO | How is the treatment for baby botulism made? From these scientists' donated blood plasma

VIDEO | How is the treatment for baby botulism made? From these scientists' donated blood plasma

Medication Reviews for Frail Patients in England Fall Short of Requirements

Medication Reviews for Frail Patients in England Fall Short of Requirements

A report by the National Audit Office (NAO) reveals that only 16% of patients with severe frailty in England received a medication review in 2024/2025, despite a 100% requirement. The report highlights deficiencies in the support provided by GPs and primary care networks, with significant local variation in care. Recommendations include setting clear requirements for GP assessments and standardizing community health services. The report emphasizes the need for improved support for frail patients to maintain their independence and optimize medication use.

Study Reveals Uranium Contamination in Breast Milk in Bihar, Raises Health Concerns

Study Reveals Uranium Contamination in Breast Milk in Bihar, Raises Health Concerns

A study published in the journal Nature has found high levels of uranium in breast milk samples from 40 lactating mothers across six districts in Bihar, India. Conducted by researchers from Mahavir Cancer Institute and AIIMS, the study detected uranium in all samples, with concentrations ranging from 0 to 5.25 g/L. The contamination is linked to environmental factors, as uranium is present in groundwater in 151 districts across 18 Indian states. The source of the uranium remains unidentified, but it poses significant health risks, particularly to infants who are more susceptible to toxic metals.

Gloucestershire Hospitals NHS Foundation Trust Extends Suspension of Home Births, Causing Panic Among Expectant Mothers

Gloucestershire Hospitals NHS Foundation Trust Extends Suspension of Home Births, Causing Panic Among Expectant Mothers

The Gloucestershire Hospitals NHS Foundation Trust has extended the suspension of home births for at least six months due to safety concerns over staffing levels. This decision has caused significant distress among expectant mothers, including Bethany Pollock, who was 38 weeks pregnant and planning a home birth for her third child. The Trust emphasized that the safety of women and babies is their top priority. The suspension aims to allow staff retraining and the implementation of a new model of care. Despite the suspension, midwife-led care remains available at Gloucestershire Royal Hospital Birth Unit and Stroud Maternity Hospital. The decision follows a government review of maternity care at underperforming services, with Gloucestershire included in the review.

Health and Human Services Secretary RFK Jr. Alters Hepatitis B Vaccine Recommendation, Raising Public Health Concerns

Health and Human Services Secretary RFK Jr. Alters Hepatitis B Vaccine Recommendation, Raising Public Health Concerns

A vaccine advisory panel led by Health and Human Services Secretary Robert F. Kennedy Jr. has voted to end the longstanding recommendation for hepatitis B vaccinations for all newborns. This decision, seen as a victory for RFK Jr., has sparked significant debate among health experts. The panel's recommendation, which is advisory in nature, suggests delaying the birth dose of the hepatitis B vaccine, allowing parents to choose whether to administer it within 24 hours of birth or delay it until at least two months later. This change has raised concerns among public health experts who warn that it could reverse decades of progress in controlling hepatitis B infections. The advisory panel's decision must still be reviewed by the CDC director and could influence state-level vaccine policies.

Analysis-Kennedy vaccine advisers 'turned back the clock' on disease prevention, experts say

Analysis-Kennedy vaccine advisers 'turned back the clock' on disease prevention, experts say

LOS ANGELES, Dec 7 (Reuters) - U.S. vaccine advisers' decision to scrap longstanding guidance on hepatitis B shots will expose more children to the harmful virus and may signal how other evidence-based vaccine policies can be undermined, doctors and disease experts said.

FDA Recalls Blood Pressure Medication Due to Potential Contamination

FDA Recalls Blood Pressure Medication Due to Potential Contamination

The Food and Drug Administration (FDA) has issued a recall for a popular blood pressure medication, bisoprolol fumarate and hydrochlorothiazide tablets, marketed under the brand name Ziac. The recall was prompted by the discovery of potential cross-contamination with ezetimibe, a cholesterol-lowering drug, during testing of reserve samples. The affected tablets, produced by Madhya Pradesh in India for Glenmark Pharmaceuticals, include various dosages ranging from 2.5 mg to 6.25 mg. The recall involves over 11,100 bottles, with specific lot numbers and expiration dates provided. This recall is classified as Class III, indicating that the use of the product is not likely to cause adverse health consequences. Bisoprolol fumarate is a beta-blocker that helps the heart beat normally, while hydrochlorothiazide is a diuretic that helps lower blood pressure by removing excess sodium and water from the body.

Research Suggests Timing of Cancer Drug Delivery Could Enhance Survival Rates

Research Suggests Timing of Cancer Drug Delivery Could Enhance Survival Rates

Recent research indicates that the timing of administering cancer drugs, particularly immune checkpoint inhibitors, can significantly impact patient outcomes. The study highlights that administering these drugs in alignment with the body's circadian rhythms, specifically in the morning when immune T cells are more active, may enhance their efficacy. This approach, known as chronotherapy, has shown promising results in improving survival rates for patients with advanced non-small cell lung cancer (NSCLC) and small cell lung cancer. The research, conducted by Zhe Huang and colleagues at Central South University in China, found that patients receiving treatment before 11:30 am had nearly double the survival rate compared to those treated later in the day. The study suggests that this timing could potentially benefit other cancer types as well.